705 related articles for article (PubMed ID: 15520807)
1. The RAF proteins take centre stage.
Wellbrock C; Karasarides M; Marais R
Nat Rev Mol Cell Biol; 2004 Nov; 5(11):875-85. PubMed ID: 15520807
[TBL] [Abstract][Full Text] [Related]
2. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
3. Second nature: biological functions of the Raf-1 "kinase".
Baccarini M
FEBS Lett; 2005 Jun; 579(15):3271-7. PubMed ID: 15943972
[TBL] [Abstract][Full Text] [Related]
4. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.
Robubi A; Mueller T; Fueller J; Hekman M; Rapp UR; Dandekar T
Biol Chem; 2005 Nov; 386(11):1165-71. PubMed ID: 16307482
[TBL] [Abstract][Full Text] [Related]
5. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
Garnett MJ; Rana S; Paterson H; Barford D; Marais R
Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
7. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
Johnson LM; James KM; Chamberlain MD; Anderson DH
Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
[TBL] [Abstract][Full Text] [Related]
8. The transition state of the ras binding domain of Raf is structurally polarized based on Phi-values but is energetically diffuse.
Campbell-Valois FX; Michnick SW
J Mol Biol; 2007 Feb; 365(5):1559-77. PubMed ID: 17137592
[TBL] [Abstract][Full Text] [Related]
9. Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival.
Muslin AJ
Trends Cardiovasc Med; 2005 Aug; 15(6):225-9. PubMed ID: 16182133
[TBL] [Abstract][Full Text] [Related]
10. Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF.
Emuss V; Garnett M; Mason C; Marais R
Cancer Res; 2005 Nov; 65(21):9719-26. PubMed ID: 16266992
[TBL] [Abstract][Full Text] [Related]
11. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky GA; Chenette EJ; Der CJ
Trends Cell Biol; 2004 Nov; 14(11):639-47. PubMed ID: 15519853
[TBL] [Abstract][Full Text] [Related]
12. Guilty as charged: B-RAF is a human oncogene.
Garnett MJ; Marais R
Cancer Cell; 2004 Oct; 6(4):313-9. PubMed ID: 15488754
[TBL] [Abstract][Full Text] [Related]
13. Regulation of c-Raf-1: therapeutic implications.
Beeram M; Patnaik A; Rowinsky EK
Clin Adv Hematol Oncol; 2003 Aug; 1(8):476-81. PubMed ID: 16258435
[TBL] [Abstract][Full Text] [Related]
14. Massive sequence perturbation of the Raf ras binding domain reveals relationships between sequence conservation, secondary structure propensity, hydrophobic core organization and stability.
Campbell-Valois FX; Tarassov K; Michnick SW
J Mol Biol; 2006 Sep; 362(1):151-71. PubMed ID: 16916524
[TBL] [Abstract][Full Text] [Related]
15. Is B-Raf a good therapeutic target for melanoma and other malignancies?
Madhunapantula SV; Robertson GP
Cancer Res; 2008 Jan; 68(1):5-8. PubMed ID: 18172288
[TBL] [Abstract][Full Text] [Related]
16. BRAF(E600) in benign and malignant human tumours.
Michaloglou C; Vredeveld LC; Mooi WJ; Peeper DS
Oncogene; 2008 Feb; 27(7):877-95. PubMed ID: 17724477
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms.
Hmitou I; Druillennec S; Valluet A; Peyssonnaux C; Eychène A
Mol Cell Biol; 2007 Jan; 27(1):31-43. PubMed ID: 17074813
[TBL] [Abstract][Full Text] [Related]
18. [The role of beta,gamma-dimers of GTP-binding proteins in the processes of hormone signal transduction].
Shpakov AO
Zh Evol Biokhim Fiziol; 2002; 38(6):512-29. PubMed ID: 12625056
[No Abstract] [Full Text] [Related]
19. [It takes two RAFs to tango].
Lavoie H; Therrien M
Med Sci (Paris); 2010 May; 26(5):459-60. PubMed ID: 20510139
[No Abstract] [Full Text] [Related]
20. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
